Failure of antiepileptic drugs in controlling seizures in epilepsy: What do we do next?

Brahyan Galindo-Mendez, Luis C. Mayor, Fernando Velandia-Hurtado, Carlos Calderon-Ospina

Resultado de la investigación: Contribución a RevistaArtículo

2 Citas (Scopus)

Resumen

© 2015 The Authors.Medically intractable epilepsy is a clinical condition of concern that arises when a patient with epilepsy suffers seizures, despite a trial of two or more antiepileptic drugs (AEDs) suitable for the type of epilepsy that are prescribed at maximum tolerated doses, does not achieve control of seizures. This diagnosis could be related to cortical dysplasias. We report the case of a 5-year-old girl with a previous normal neurological development and no family history of epilepsy who presented with focal-type seizures at age 4. She started treatment by taking different AEDs for seizure control. She continued having frequent seizures that sometimes progressed to generalized seizures and status epilepticus. After a focal cortical resection performed in the area where interictal spikes were detected, the pathology confirmed a type IIb cortical dysplasia as the cause of the epilepsy. This article discusses cortical dysplasias as a cause of pharmacoresistant epilepsy and its treatment.
Idioma originalEnglish (US)
Páginas (desde-hasta)6-8
Número de páginas3
PublicaciónEpilepsy and Behavior Case Reports
DOI
EstadoPublished - mar 1 2015

Huella dactilar

Anticonvulsants
Epilepsy
Seizures
Malformations of Cortical Development
Maximum Tolerated Dose
Status Epilepticus
Drug and Narcotic Control
Pathology
Therapeutics

Citar esto

@article{9b15155b803f4a4fa997a890dec62da9,
title = "Failure of antiepileptic drugs in controlling seizures in epilepsy: What do we do next?",
abstract = "{\circledC} 2015 The Authors.Medically intractable epilepsy is a clinical condition of concern that arises when a patient with epilepsy suffers seizures, despite a trial of two or more antiepileptic drugs (AEDs) suitable for the type of epilepsy that are prescribed at maximum tolerated doses, does not achieve control of seizures. This diagnosis could be related to cortical dysplasias. We report the case of a 5-year-old girl with a previous normal neurological development and no family history of epilepsy who presented with focal-type seizures at age 4. She started treatment by taking different AEDs for seizure control. She continued having frequent seizures that sometimes progressed to generalized seizures and status epilepticus. After a focal cortical resection performed in the area where interictal spikes were detected, the pathology confirmed a type IIb cortical dysplasia as the cause of the epilepsy. This article discusses cortical dysplasias as a cause of pharmacoresistant epilepsy and its treatment.",
author = "Brahyan Galindo-Mendez and Mayor, {Luis C.} and Fernando Velandia-Hurtado and Carlos Calderon-Ospina",
year = "2015",
month = "3",
day = "1",
doi = "10.1016/j.ebcr.2015.03.004",
language = "English (US)",
pages = "6--8",
journal = "Epilepsy and Behavior Case Reports",
issn = "2213-3232",
publisher = "Elsevier BV",

}

Failure of antiepileptic drugs in controlling seizures in epilepsy: What do we do next? / Galindo-Mendez, Brahyan; Mayor, Luis C.; Velandia-Hurtado, Fernando; Calderon-Ospina, Carlos.

En: Epilepsy and Behavior Case Reports, 01.03.2015, p. 6-8.

Resultado de la investigación: Contribución a RevistaArtículo

TY - JOUR

T1 - Failure of antiepileptic drugs in controlling seizures in epilepsy: What do we do next?

AU - Galindo-Mendez, Brahyan

AU - Mayor, Luis C.

AU - Velandia-Hurtado, Fernando

AU - Calderon-Ospina, Carlos

PY - 2015/3/1

Y1 - 2015/3/1

N2 - © 2015 The Authors.Medically intractable epilepsy is a clinical condition of concern that arises when a patient with epilepsy suffers seizures, despite a trial of two or more antiepileptic drugs (AEDs) suitable for the type of epilepsy that are prescribed at maximum tolerated doses, does not achieve control of seizures. This diagnosis could be related to cortical dysplasias. We report the case of a 5-year-old girl with a previous normal neurological development and no family history of epilepsy who presented with focal-type seizures at age 4. She started treatment by taking different AEDs for seizure control. She continued having frequent seizures that sometimes progressed to generalized seizures and status epilepticus. After a focal cortical resection performed in the area where interictal spikes were detected, the pathology confirmed a type IIb cortical dysplasia as the cause of the epilepsy. This article discusses cortical dysplasias as a cause of pharmacoresistant epilepsy and its treatment.

AB - © 2015 The Authors.Medically intractable epilepsy is a clinical condition of concern that arises when a patient with epilepsy suffers seizures, despite a trial of two or more antiepileptic drugs (AEDs) suitable for the type of epilepsy that are prescribed at maximum tolerated doses, does not achieve control of seizures. This diagnosis could be related to cortical dysplasias. We report the case of a 5-year-old girl with a previous normal neurological development and no family history of epilepsy who presented with focal-type seizures at age 4. She started treatment by taking different AEDs for seizure control. She continued having frequent seizures that sometimes progressed to generalized seizures and status epilepticus. After a focal cortical resection performed in the area where interictal spikes were detected, the pathology confirmed a type IIb cortical dysplasia as the cause of the epilepsy. This article discusses cortical dysplasias as a cause of pharmacoresistant epilepsy and its treatment.

U2 - 10.1016/j.ebcr.2015.03.004

DO - 10.1016/j.ebcr.2015.03.004

M3 - Article

C2 - 26101746

SP - 6

EP - 8

JO - Epilepsy and Behavior Case Reports

JF - Epilepsy and Behavior Case Reports

SN - 2213-3232

ER -